Charlotte's Web Holdings (CWBHF) Cost of Revenue (2021 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Cost of Revenue came in at $6.0 million in Q1 2026, down 1.28% year-on-year from $6.0 million in Q1 2025, and down 28.45% on a QoQ basis from $8.3 million in Q4 2025.
Charlotte's Web Holdings (CWBHF) Cost of Revenue (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 6 years of Cost of Revenue data on file, last reported at $6.0 million in Q1 2026.
- On a quarterly basis, Cost of Revenue fell 1.28% year-over-year to $6.0 million in Q1 2026; TTM through Mar 2026 was $28.1 million, a 3.78% decrease from a year earlier, with the FY2025 full-year figure at $28.2 million, down 0.74% from the prior year.
- Cost of Revenue for Q1 2026 stood at $6.0 million, down from $8.3 million in the prior quarter.
- Over the last five years, Cost of Revenue for CWBHF reached as high as $29.4 million in Q4 2022 and fell as low as $5.2 million in Q1 2024.
- Historically, Cost of Revenue has averaged $8.5 million across 5 years, with a median of $7.1 million in 2023.
- Across the five-year window, Cost of Revenue jumped 42.74% in 2022 and tumbled 76.07% in 2023, its largest moves.
- Year by year, Cost of Revenue stood at $29.4 million in 2022, then tumbled by 76.07% to $7.0 million in 2023, then increased by 7.53% to $7.6 million in 2024, then climbed by 9.9% to $8.3 million in 2025, then declined by 28.45% to $6.0 million in 2026.
- Per Business Quant data, the three most recent Cost of Revenue figures were $6.0 million in Q1 2026, $8.3 million in Q4 2025, and $7.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | 5.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.96 Mn |
| Mar 31, 2026 | 5.96 Mn |
| Dec 31, 2025 | 8.32 Mn |
| Dec 31, 2025 | 8.32 Mn |
| Sep 30, 2025 | 7.03 Mn |
| Sep 30, 2025 | 7.03 Mn |
| Jun 30, 2025 | 6.82 Mn |
| Jun 30, 2025 | 6.82 Mn |
| Mar 31, 2025 | 6.03 Mn |
| Mar 31, 2025 | 6.03 Mn |
| Dec 31, 2024 | 7.57 Mn |
| Dec 31, 2024 | 7.57 Mn |
| Sep 30, 2024 | 5.91 Mn |
| Sep 30, 2024 | 5.91 Mn |
| Jun 30, 2024 | 9.71 Mn |
| Jun 30, 2024 | 9.71 Mn |
| Mar 31, 2024 | 5.21 Mn |
| Mar 31, 2024 | 5.21 Mn |
| Dec 31, 2023 | 7.04 Mn |
| Dec 31, 2023 | 7.04 Mn |